Page 34 - Recognizing axial spondyloarthritis - Janneke de Winter

CHAPTER TWO
psoriatic arthritis. Arthritis Rheum
2009;60:966–75.
12. Noordenbos T, Yeremenko N, Gofita
I, Sande M van de, Tak PP, Caňete JD, et al. Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis. Arthritis Rheum 2012;64:99–109.
13. Yeremenko N, Noordenbos T, Cantaert T, Tok M van, Sande M van de, Cañete JD, et al. Disease- specific and inflammation- independent stromal alterations in spondylarthritis synovitis. Arthritis Rheum 2013;65:174–85.
14. Dougados M, Baeten D. Spondyloarthritis. Lancet 2011;377:2127–37.
15. Rudwaleit M, Heijde D van der, Landewé R, Akkoc N, Brandt J, Chou CT, et al. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011;70:25–31.
16. Rudwaleit M, Heijde D van der, Landewe R, Listing J, Akkoc N, Brandt J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009;68:777–783.
17. Winter JJ de, Mens LJ van, Heijde D van der, Landewé R, Baeten DL. Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non- radiographic axial spondyloarthritis: a meta-analysis. Arthritis Res Ther 2016;18:196.
18. Rudwaleit M, Heijde D van der,
Landewe R, Listing J, Akkoc N, Brandt J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009;68:777–783.
19. Linden S Van der, Valkenburg H, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheumatol 1984;27:361–8.
20. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P CA. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286–2291.
21. MacHado P, Landewé R, Lie E, Kvien TK, Braun J, Baker D, et al. Ankylosing Spondylitis Disease Activity Score (ASDAS): Defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis 2011;70:47–53.
22. Río-Martínez P del, Navarro-Compán V, Díaz-Miguel C, Almodóvar R, Mulero J, Miguel E De. Similarities and differences between patients fulfilling axial and peripheral ASAS criteria for spondyloarthritis: Results from the Esperanza Cohort. Semin Arthritis Rheum 2016;45:400–403.
23. Heijde D Van Der, Ramiro S, Landewé R, Baraliakos X, Bosch F Van Den, Sepriano A, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 2017;76:978–991.
24. Braun J, Zochling J, Baraliakos X,
32